Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer To Audit Managed Care Grants Under Lipitor “Best Price” Settlement

Executive Summary

Pfizer will fund an independent review of its managed care expenditures and best price calculation practices as part of a settlement of a Department of Justice investigation into Lipitor price reporting
Advertisement

Related Content

Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement
Fibromyalgia Trial Endpoints Should Be Validated In Real Time – FDA Cmte.
Fibromyalgia clinical design
Medicaid Rebate Cases To Focus On “Slam Dunks”; Industry Wants Guidance
CMS Wants Bigger Medicaid Rebates, Elimination Of “Best Price”
IG Has Overly “Negative” View Of Sales Incentives, Pfizer Counsel Says
Neurontin Pain Claim Follows Cmte. Preference For Individual Etiologies
TAP To Audit Marketing Documents Related To Top Lupron, Prevacid Buyers
TAP To Audit Marketing Documents Related To Top Lupron, Prevacid Buyers
Bayer Drug Prices To Be Monitored By HHS Under Medicaid Fraud Settlement
Advertisement
UsernamePublicRestriction

Register

PS040737

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel